Search
for
Sort by
Research 271–300 of 1000+
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- Aim to alleviate alopecia areata with newly available agents
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- New Treatment Options for Alopecia Areata
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- New Treatments for Hair Loss
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Ritlecitinib in severe alopecia areata: a profile of its use
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Janus Kinase inhibitors in dermatology: a review
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- 1108 Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Review of Promising Off-Label Use of Deucravacitinib
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Androgenetic Alopecia: Therapy Update
- Dissolving microneedles for alopecia treatment
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata